Opioid involvement in epileptogenic and neurovisceral activity.
Pinsky
C
C
Department of Pharmacology, University of Manitoba, Faculty of Medicine, Winnipeg, Canada.
Bose
R
R
Hall
A
A
Glavin
G B
GB
D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D000818:Animals; D004064:Digestive System / Q000187:drug effects; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives / Q000494:pharmacology; D004827:Epilepsy / Q000139:chemically induced / Q000503:physiopathology* / Q000517:prevention & control; D007608:Kainic Acid / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000633:toxicity; D008297:Male; D051379:Mice; D009270:Naloxone / Q000494:pharmacology; D009420:Nervous System / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology*
D011759:Pyrrolidines; D011957:Receptors, Opioid; D009270:Naloxone; D004744:Enkephalin, Methionine; D004743:Enkephalin, Leucine; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; C036405:ICI 154129; C012301:domoic acid; C028208:metkephamid; D007608:Kainic Acid